enVVeno Medical NVNO
NASDAQ NVNO
$10.62 +0.14 (+1.31%)
At close: Aug 20, 2026 · 1:10 PM UTC

enVVeno Medical (NVNO) Total Non-Current Liabilities (2017)

enVVeno Medical (NVNO) posted quarterly Total Non-Current Liabilities of $8.2 million for Q4 2017.

enVVeno Medical (NVNO) Total Non-Current Liabilities (2017) Analysis & Trends

enVVeno Medical's Total Non-Current Liabilities history runs 1 years deep, the most recent figure standing at $8.2 million for Q4 2017.

  • In Q4 2017, Total Non-Current Liabilities changed N/A year-over-year to $8.2 million; the TTM figure through Dec 2017 stood at $8.2 million (changed N/A YoY), while the FY2017 annual figure was $8.2 million, changed N/A from the prior year.
  • Total Non-Current Liabilities for Q4 2017 stood at $8.2 million.
  • The five-year high for Total Non-Current Liabilities was $8.2 million in Q4 2017, with the low at $8.2 million in Q4 2017.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Total Non-Current Liabilities (Qtr)
1 Abbott Laboratories 199.24 Bn 193.64 Bn 7.27 Bn -
2 Stryker 128.63 Bn 125.15 Bn 4.50 Bn 21.28 Bn
3 Medtronic 119.19 Bn 109.97 Bn 6.41 Bn 40.90 Bn
4 Boston Scientific 73.51 Bn 72.97 Bn 3.85 Bn 42.74 Bn
5 Edwards Lifesciences 52.11 Bn 47.85 Bn 1.35 Bn 2.57 Bn
6 Dexcom 34.64 Bn 32.70 Bn 830.00 Mn 3.68 Bn
7 GE HealthCare Technologies 34.01 Bn 31.90 Bn 2.18 Bn 23.89 Bn
8 Koninklijke Philips 26.40 Bn 23.08 Bn 4.55 Bn 9.07 Bn
9 Steris 23.14 Bn 22.65 Bn 684.20 Mn 3.44 Bn
10 enVVeno Medical 7.12 Mn 7.12 Mn - -

Historic Data

Download Data
DateValue
Dec 31, 2017 8.15 Mn